NCT07395700

Brief Summary

This observational study evaluates the psychometric properties of the Behavioral Activation for Depression Scale (BADS) in individuals with substance use disorders. The study examines the scale's internal structure, reliability, and validity using data from 289 participants who completed the BADS. External and incremental validity analyses were conducted in a subsample of 127 participants for whom additional clinical measures were available, including assessments of symptom severity, anxiety, impulsivity, and anger expression. This approach reflects the availability of complete data for each analytic component and allows for a comprehensive evaluation of the BADS in a clinical population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
289

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 18, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2025

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

January 7, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 9, 2026

Completed
Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

1.7 years

First QC Date

January 7, 2026

Last Update Submit

February 6, 2026

Conditions

Keywords

Behavioral ActivationPsychometric ValidationSubstance Use DisordersAddictionExternal ValidityIncremental ValidityClinical AssessmentBehavioral FunctioningDepressionFunctional Impairment

Outcome Measures

Primary Outcomes (1)

  • Psychometric Validity of the Behavioral Activation for Depression Scale (BADS)

    Psychometric properties of the Behavioral Activation for Depression Scale (BADS), including internal structure (confirmatory factor analysis), internal consistency reliability (Cronbach's alpha / omega), and construct validity (convergent and discriminant validity), assessed using self-report data collected at a single time point in individuals with substance use disorders. Subscale scores will also be examined, with higher scores reflecting greater expression of the respective behavioral domains.

    Baseline, pre-intervention (single cross-sectional assessment at study enrollment)

Secondary Outcomes (2)

  • Convergent and Discriminant Validity of the Behavioral Activation for Depression Scale With the Borderline Symptom List-23

    Baseline, pre-intervention (single cross-sectional assessment conducted at study enrollment)

  • Convergent Validity of the Behavioral Activation for Depression Scale With the Environmental Reward Observation Scale

    Baseline, pre-intervention (single cross-sectional assessment at study enrollment)

Study Arms (1)

Individuals With Substance Use Disorders

Single clinical group composed of adults receiving treatment for substance use disorders who completed the Behavioral Activation for Depression Scale (BADS) and additional self-report measures as part of a cross-sectional observational study.

Eligibility Criteria

Age18 Years - 68 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adults receiving residential treatment for substance use disorders in a therapeutic community setting. Participants represent a clinically relevant population characterized by difficulties in mood regulation, behavioral activation, emotional dysregulation, and related psychological symptoms commonly associated with substance use disorders.

You may qualify if:

  • Adults aged 18 years or older.
  • Currently receiving treatment or undergoing clinical evaluation for substance use disorders in a therapeutic or clinical setting.
  • Ability to read and understand Spanish.
  • Ability to provide informed consent.
  • Completion of the Behavioral Activation for Depression Scale and at least one additional study questionnaire.

You may not qualify if:

  • Severe cognitive impairment or acute psychiatric symptoms that prevent accurate self-reporting.
  • Incomplete or missing data on key study measures.
  • Current intoxication or acute withdrawal symptoms at the time of assessment that interfere with completing questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Comunidad Terapéutica Under The Tree

Ajijic, Jalisco, 45920, Mexico

Location

MeSH Terms

Conditions

Substance-Related DisordersBehavior, AddictiveDepression

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersCompulsive BehaviorImpulsive BehaviorBehaviorBehavioral Symptoms

Study Officials

  • Lauro Gutiérrez Castro

    Under The Tree Therapeutic Community

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Invetigator

Study Record Dates

First Submitted

January 7, 2026

First Posted

February 9, 2026

Study Start

March 18, 2024

Primary Completion

November 30, 2025

Study Completion

December 22, 2025

Last Updated

February 9, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations